Twitxy Saved

Chris Morash

@ottdoc

director, the ottawa hospital prostate cancer centre. doctor who loves going to work. head of uro-oncology ottawa hospital.
ottawa Joined May 2009
997 Following 430 Followers 218 Posts

Latest posts 5

Chris Morash @ottdoc
Agree. A missed opportunity for sure as mixed results from scattered case series have caused the demise of BCG/IFN. We have many grateful patients who still have their bladder many years later who can thank this drug combo. Onward and hopefully upward with IO and viral trials.
As BCG/Interferon falls out of our armamentarium, tough to reconcile with the fairly large numbers of patients in Ottawa with durable salvage with this treatment. I wonder if we missed an opportunity for RCT on a good treatment. @Lukelavallee @ottdoc @icagiannos
View quoted post on X